Charles C Peyton

6PUBLICATIONS
40CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markersOther creative arts and writing not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 13, 2026
Contemporary Role for Blue Light Cystoscopy Across the Bladder Cancer Disease Spectrum.

Ethan Wan, Caroline Wade, Aditya Sathe

|Dec 15, 2025
Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer.

John L Gore, Erika M Wolff, Michael G Nash

|Dec 03, 2025
Gemcitabine Intravesical System Plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: SunRISe-4 Primary Analysis and Biomarker Results.

Andrea Necchi, Félix Guerrero-Ramos, Paul L Crispen

|Nov 11, 2025
Patient-Reported Outcomes Following UGN-102 Treatment in Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: An Analysis of 3 Clinical Trials.

Charles C Peyton, Max Kates, Anagha Nadkarni

|Jun 11, 2025
Utility of Tumor-Informed Circulating Tumor DNA for Monitoring Treatment Response in Nonmetastatic, Locally Advanced Penile and Primary Urethral Cancers.

Kartik R Patel, Sol C Moon, Luke A Shumaker

|Dec 05, 2024
Editorial Comment.

Alireza Dehghanmanshadi, Charles C Peyton, Soroush Rais-Bahrami

Pageof 1

Frequent Collaborators

2 joint publications

Neal Shore

1 joint publications

Alireza Dehghanmanshadi

1 joint publications

Soroush Rais-Bahrami

1 joint publications

Kartik R Patel